Browsing by Author "Božinović, Nenad (56614042000)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication An analysis of published cases of cutting balloon use in spontaneous coronary artery dissection(2023) ;Maričić, Bojan (57207569284) ;Perišić, Zoran (21834957000) ;Kostić, Tomislav (26023450500) ;Božinović, Nenad (56614042000) ;Petrović, Milovan (16234216100) ;Čanković, Milenko (57204401342) ;Mehmedbegović, Zlatko (55778381000) ;Juričić, Stefan (57203033137) ;Vasilev, Vladimir (57224717435) ;Dakić, Sonja (55358323700) ;Perišić, Jelena (58713206400) ;Milošević, Jelena (59793378300) ;Bojanović, Mihajlo (57193237478) ;Nikolić, Miroslav (57194436285) ;Maričić, Tijana (57202990526)Apostolović, Svetlana (13610076800)Introduction: SCAD involves a sudden tear or separation within the layers of the coronary artery wall, resulting in blood flow obstruction and subsequent myocardial ischemia. Materials and methods: A comprehensive literature search was conducted to identify relevant published cases of cutting balloon use in patients diagnosed with spontaneous coronary artery dissection. Electronic databases including PubMed, MEDLINE, Embase, Cochrane Library and Google Scholar were systematically searched from inception until the present using terms “cutting balloon,” “SCAD,” “acute coronary syndrome,” “intramural hematoma,” and “angioplasty.” Results: A total of 32 published cases of cutting balloon use in spontaneous coronary artery dissection were analyzed in this study. The majority of the patients included in the analysis were female without prior history of cardiovascular disease. The median age of the SCAD population was approximately 46 years. The most frequently affected artery in SCAD cases was the Left Anterior Descending artery. Intravascular ultrasound was utilized more frequently than other modalities of adjunctive imaging techniques. The most frequent complication was the distal propagation of hematoma. Despite the successful dilation achieved with the cutting balloon, in some cases stenting was required to provide additional support. Conclusion: The results of this analysis demonstrate that cutting balloon use in SCAD cases yields favorable outcomes. 2023 Maričić, Perišić, Kostić, Božinović, Petrović, Čanković, Mehmedbegović, Juričić, Vasilev, Dakić, Perišić, Milošević, Bojanović, Nikolić, Maričić and Apostolović. - Some of the metrics are blocked by yourconsent settings
Publication Time to reconsider the way of selecting antihypertensives for hypertensive left ventricular hypertrophy(2025) ;Koraćević, Goran (24341050000) ;Stojanović, Milovan (57188923072) ;Zdravković, Marija (24924016800) ;Janković Tomasević, Ruzica (55246100200) ;Ćirić Zdravković, Snežana (56427994000) ;Božinović, Nenad (56614042000) ;Cvetković, Predrag (57188930156) ;Pavlović, Milorad (57201659222)Pavlović, Dimitrije (57701387500)Introduction: Hypertensive left ventricular hypertrophy (HTN LVH) is a highly prevalent high-risk condition, and the recommendations for HTN LVH treatment are essentially unchanged for several decades. Areas covered: The current therapeutic approach to HTN LVH is to choose antihypertensive drugs according to their ability to reverse left ventricular (LV) remodeling. On the other hand, for the majority arterial hypertension (HTN) patients we should start treatment with a combination of different antihypertensive drugs. Therefore, the goal of antihypertensive treatment of HTN LVH should be adapted to the current recommendation in other parts of guidelines. The recommendation we need is not only which individual drug, but rather which combination of two antihypertensive agents is optimal for reversed LV remodeling. Expert opinion: In this paper, we pointed out that treatment recommendation for HTN LVH can be updated in a similar way as therapy for the whole HTN population–by recommending a combination of two or three antihypertensives in a single pill. Clinicians should be directly advised what is the first- and what the second-line combination of antihypertensives for HTN LVH in evidence-based medicine. Therefore, we suggest that combination treatment should be studied, compared and then recommended also for very prevalent higher-risk HTN LVH patients. © 2025 Informa UK Limited, trading as Taylor & Francis Group.
